newsfilter
← Latest News
GlobeNewswire·

Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026

MINNEAPOLIS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the